Docu Liquid

Product NDC: 17856-0771
11-digit product format: 178560771
Labeler code: 17856
Product ID: 17856-0771_3b3f3045-55db-5ed5-e063-6294a90aab75
Type: HUMAN OTC DRUG
Nonproprietary name: Docusate Sodium
Dosage form: LIQUID
Route: ORAL
Labeler: ATLANTIC BIOLOGICALS CORP.
Application: M
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 1997-08-01
Substance: DOCUSATE SODIUM
Active strength: 50 mg/5mL
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	17856-0771	17856-0771-1	D	Discontinued by firm		2026-10-12
excluded package	package	17856-0771	17856-0771-2	D	Discontinued by firm		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 19 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0771-2	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0771-1	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0771-2	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0771-1	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0771-2	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0771-1	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0771-2	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0771-1	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	17856-0771-2	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	17856-0771-1	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	17856-0771-2	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	17856-0771-1	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	17856-0771-2	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	17856-0771-1	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Docu Liquid
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DOCUSATE SODIUM	50 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
F05Q2T2JA0	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1248119	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f4ed0721-3be9-4108-a6c9-dbbe115249e9	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
17856-0771-1	2024-05-24	Drug Facts
17856-0771-2	2024-05-24	Drug Facts
17856-0771-1	2022-01-28	Drug Facts
17856-0771-2	2022-01-28	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
17856-0771-1	Docu Liquid	50 in 1 BOX, UNIT-DOSE	LIQUID	50	3
17856-0771-1	Docu Liquid	25 mL in 1 CUP, UNIT-DOSE	LIQUID	25	3
17856-0771-2	Docu Liquid	10 mL in 1 CUP, UNIT-DOSE	LIQUID	10	3
17856-0771-2	Docu Liquid	72 in 1 BOX, UNIT-DOSE	LIQUID	72	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
17856-0771-2	ML - Milliliter	17856-0771	c48e96da-0bd0-41c4-8dbf-13b1c32d8db9	1	2022-09-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17856-0771	DOCU LIQUID (DOCUSATE SODIUM) LIQUID [ATLANTIC BIOLOGICALS CORP.]	2	Current NDC, Legacy NDC, 4 package rows	20240526_f4ed0721-3be9-4108-a6c9-dbbe115249e9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 5 of 6 · 111 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Menthol Pain Relieving Cream with Menthol 10%	MENTHOL 10% CREAM	ONE2ZEE LIMITED LIABILITY COMPANY	ae09e93f-3988-4477-ae53-b2f3df9769fb	2025-05-05	Warnings	Exact identifier application number: M
Anua Zero-Cast Moisturizing Finish Sunscreen SPF 50	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	ENGLEWOOD LAB, INC.	edf07b7f-46fb-4915-b2ea-83d852617f60	2025-04-10	Warnings	Exact identifier application number: M
BRONCOCHEM KIDS COLD AND FLU	ACETAMINOPHEN-PHENYLEPHRINE HCL-GUAIFENESIN	LABORATORIO MAGNACHEM INTERNATIONAL SRL	b6559fb9-2dea-49c0-a274-3e77741a0ffd	2025-03-23	Warnings	Exact identifier application number: M
BRONCOCHEM MAXIMUM COUGH	DEXTROMETHORPHAN HBR-GYAIFENESIN	LABORATORIO MAGNACHEM INTERNATIONAL SRL	deecdb72-4cdb-4d6f-972f-a425a91afa5a	2025-03-23	Warnings	Exact identifier application number: M
BRONCOCHEM MAXIMUM COUGH NIGHT	DEXTROMETHORPHAN HBR-PYRILAMINE MALEATE	LABORATORIO MAGNACHEM INTERNATIONAL SRL	dffdfa2c-a52e-4606-9b07-c8993e499f09	2025-03-23	Warnings	Exact identifier application number: M
BRONCOCHEM EXPECTORANT II	ACETAMINOPHEN-CHLORPHENIRAMINE MALEATE-DEXTROMETHORPHAN HBR-GUAIFENESIN-PHENYLEPHRINE HCL	LABORATORIO MAGNACHEM INTERNATIONAL SRL	1fb86dcb-6f51-4c29-99ad-a5a9b7b7526a	2025-03-23	Warnings	Exact identifier application number: M
BRONCOCHEM MAXIMUM COUGH KIDS	DEXTROMETHORPHAN HBR-GUAIFENESIN	LABORATORIO MAGNACHEM INTERNATIONAL SRL	b0fd2f2f-5cc4-4813-8f99-c78fbe898656	2025-03-13	Warnings	Exact identifier application number: M
Menthol Pain Relief Gel Patch	MENTHOL PAIN RELIEF GEL PATCH	ONE2ZEE LIMITED LIABILITY COMPANY	eab185d6-2a54-489d-8114-fe8088624ba4	2025-03-04	Warnings	Exact identifier application number: M
Lidocaine 4% Pain Relief Gel Patch	LIDOCAINE 4% PAIN RELIEF GEL PATCH	ONE2ZEE LIMITED LIABILITY COMPANY	8e5a4ef4-b928-44b3-842c-92f1531af75b	2025-03-03	Warnings	Exact identifier application number: M
gas relief	SIMETHICONE	Strategic Sourcing Services LLC	23005295-c5f2-4a76-8431-4a9b8d817d4d	2025-01-03	Warnings	Exact identifier application number: M
Foster and Thrive infants Gas relief	SIMETHICONE	Strategic Sourcing Services LLC	824c9dff-0a26-4710-a25b-39df631d6fa6	2024-12-13	Warnings	Exact identifier application number: M
BRONCOCHEM COLD AND FLU TEA	ACETAMINOPHEN-PHENYLEPHRINE HYDROCHLORIDE-CHLORPHENIRAMINE MALEATE	LABORATORIO MAGNACHEM INTERNATIONAL SRL	b7d3f54e-59ef-4b85-a88d-b053058dc1f6	2024-12-12	Warnings	Exact identifier application number: M
HYSAN PAIN RELIEVER	METHYL SALICYLATE, CAMPHOR (SYNTHETIC)	HYSAN PHARMACEUTICAL CO LTD	bad73234-c204-40a8-8176-45c75ae500c8	2024-10-07	Warnings	Exact identifier application number: M
HYSAN ANALGESIC	METHYL SALICYLATE, CAMPHOR (SYNTHETIC)	HYSAN PHARMACEUTICAL CO LTD	99a13b0a-1d77-479e-ba99-2cfa638de339	2024-10-04	Warnings	Exact identifier application number: M
HYSAN HUO LU MEDICATED	METHYL SALICYLATE, CAMPHOR (SYNTHETIC)	HYSAN PHARMACEUTICAL CO LTD	fe9eeaff-fcbf-4287-9f17-bcf1822bf35b	2024-10-04	Warnings	Exact identifier application number: M
HYSAN HUA TUO MEDICATED	METHYL SALICYLATE	HYSAN PHARMACEUTICAL CO LTD	b84c4d33-5a77-46e0-b04e-32f73967bd1c	2024-10-04	Warnings	Exact identifier application number: M
HYSAN HUA TUO HUO LU	METHYL SALICYLATE, CAMPHOR (SYNTHETIC)	HYSAN PHARMACEUTICAL CO LTD	cd2288c4-9909-43c1-91da-b15545b09788	2024-10-04	Warnings	Exact identifier application number: M
CLARINS - ROLL-ON DEODORANT Aluminum Chlorohydrate - Antiperspirant, Long-lasting Alcohol-free	ALUMINUM CHLOROHYDRATE	Laboratoires Clarins	412116a1-f9af-4c03-85e0-aad5738dd797	2024-08-05	Warnings	Exact identifier application number: M
BRONCOCHEM MAXIMUM COUGH NIGHT	DEXTROMETHORPHAN HBR-PYRILAMINE MALEATE	LABORATORIO MAGNACHEM INTERNATIONAL SRL	1a3ed214-e09b-4266-b68b-39e7c3127d26	2024-04-22	Warnings	Exact identifier application number: M
CLARUS Antifungal	TOLNAFTATE	Clinical Therapeutic Solutions	835c3c23-fc3c-404e-8e87-5a0176126730	2024-02-28	Warnings	Exact identifier application number: M

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1248119	docusate sodium 50 MG in 5 mL Oral Suspension	PSN	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 10 MG/ML Oral Suspension	SCD	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 100 MG per 10 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 150 MG per 15 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 50 MG per 5 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	DOSS Sodium 10 MG/ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
17856-0771-1	17856077101	50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0771-1) > 25 mL in 1 CUP, UNIT-DOSE	2020-01-31	0000-00-00	No	No	Current
17856-0771-2	17856077102	72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0771-2) > 10 mL in 1 CUP, UNIT-DOSE	2020-01-31	0000-00-00	No	No	Current